title: Knowledge of vitreomacular traction (VMT) scenarios: Is doing nothing still a beneficial alternative and, if so, when?
authors.affiliation: Centre for Ophthalmology, Eberhard-Karls-University, Schleichstr. 12, 72076, Tuebingen, Germany. focke.ziemssen@med.uni-tuebingen.de.
authors.forename: Focke
authors.initials: F
authors.lastname: Ziemssen
authors.affiliation: Centre for Ophthalmology, Eberhard-Karls-University, Schleichstr. 12, 72076, Tuebingen, Germany.
authors.forename: Karl Ulrich
authors.initials: KU
authors.lastname: Bartz-Schmidt
authors.affiliation: Centre for Ophthalmology, Eberhard-Karls-University, Schleichstr. 12, 72076, Tuebingen, Germany.
authors.forename: Spyros
authors.initials: S
authors.lastname: Dimopoulos
mesh_terms: D005341:Fibrinolysin / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D010446:Peptide Fragments / Q000627:therapeutic use; D012164:Retinal Diseases / Q000175:diagnosis* / Q000628:therapy; D000267:Tissue Adhesions; D041623:Tomography, Optical Coherence; D014821:Vitrectomy; D014822:Vitreous Body / Q000187:drug effects / Q000473:pathology*; D020255:Vitreous Detachment / Q000139:chemically induced; D057832:Watchful Waiting
chemical_list: D005343:Fibrinolytic Agents; D010446:Peptide Fragments; C054561:microplasmin; D005341:Fibrinolysin
keywords: Natural history; Ocriplasmin; SD-OCT; Vitrectomy; Vitreomacular adhesion